Belvedere Trading
ICPT

Belvedere Trading’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Belvedere Trading’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14,967
Closed -$216K – 453
2022
Q2 		$216K Sell
14,967
-861
-5% -$13.8K 0.01% 177
2022
Q1 		$263K Buy
15,828
+9,707
+159% +$152K 0.01% 198
2021
Q4 		$94K Sell
6,121
-237
-4% -$4K ﹤0.01% 312
2021
Q3 		$104K Buy
+6,358
New +$102K ﹤0.01% 350

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Belvedere Trading's ICPT Position: Q3 2022 in Review

Belvedere Trading sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2022, closing a stake of 14,967 shares — an estimated $216K sold.

Belvedere Trading first reported a position in ICPT in Q3 2021 and held it in 4 quarters. The position peaked at $263K in Q1 2022. 156 funds tracked by Wall St. Rank hold ICPT as of Q3 2022.

  • Belvedere Trading reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • Belvedere Trading sold 14,967 Intercept Pharmaceuticals, Inc. shares in Q3 2022, an estimated $216K.
  • Belvedere Trading first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2021 and held it in 4 quarters.
  • Belvedere Trading's Intercept Pharmaceuticals, Inc. position peaked at $263K in Q1 2022.
  • 156 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2022.

Based on Belvedere Trading's 13F filing for Q3 2022, filed 26 Oct 2022.